tag:blogger.com,1999:blog-30206473.post7377763695333233019..comments2023-10-23T11:24:13.532-04:00Comments on Diabetes Update: Cutting through the Jardiance Study Hype: Be Cautious with this Drug!Jennyhttp://www.blogger.com/profile/17384082448952856117noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-30206473.post-42771291692928752882015-09-28T13:34:21.256-04:002015-09-28T13:34:21.256-04:00The fact that various endpoints that should be rel...The fact that various endpoints that should be related (e.g. fatal stroke v. non-fatal, silent v. symptomatic MI) responded in different ways suggests to me that the results are a statistical anomaly. There is no a priori reason to think that this SGLT2 is any different than the others already on the market. Even in relatively large clinical trials these sorts of anomalies can happen -- it is the@NaturalWorkwearhttps://www.blogger.com/profile/12779900432328065035noreply@blogger.com